Harvard Malaria Forum
Malaria eradication will require close collaboration and understanding between scientific experts, policy makers and implementers. The annual Harvard Malaria Forum convenes multidisciplinary experts at critical junctures where information needs to be synthesized to effect a global or regional decision, or to establish a policy or research agenda. A primary objective of the Forum is to facilitate the prioritization of issues at the nexus of world health and globalization and incorporate the perspectives of both the health and non-health public and private sectors.
Business Approaches to Global Malaria
The inaugural Harvard Malaria Forum was sponsored by the Mossavar-Rahmani Center for Business and Government at the Harvard Kennedy School (HKS) and Harvard Global Health Institute on January 30, 2013 at HKS. Centered on the topic Business Approaches to Global Malaria, the forum drew on the expertise of both Harvard faculty working in the fields of business and public health, and experts from the private and public sectors. Hosted by Thomas Healey, Senior Fellow, Mossavar-Rahmani Center for Business and Government and moderated by Rajesh Garg, Director, McKinsey & Co, the event included Suzanne McCarron, President, ExxonMobil Foundation; Jane Nelson, Senior Fellow and Director of Corporate Social Responsibility Initiative, HKS; Regina Rabinovich, ExxonMobil Malaria Scholar in Residence, Harvard University; Daniel Stern, Co-CEO, Reservoir Capital Group; Naohiro Takahashi, President, Sumitomo Chemical America; Jay Winsten, Associate Dean for Health Communication, Harvard T.H. Chan School of Public Health: and Dyann Wirth, Professor and Chair, Department of Immunology & Infectious Diseases, Harvard T.H. Chan School of Public Health.